This activity will provide up-to-date information regarding forensic medicine and death investigation with an emphasis on – (1) novel psychoactive drugs; (2) forensic toxicology; (3) opioid pharmacology, toxicology, and MAT; (4) forensic anthropology; (5) mass disasters; (6) courtroom testimony; (7) FSA’s Cold Case Advisory Commission; (8) responding to public records requests; (9) pediatric deaths; (10) the Florida PDMP; and (11) unusual suicides.
Please contact Dr. Bruce Goldberger with questions: bruce-goldberger@ufl.edu
Refund/Cancellation Policy:
Written refund requests must be received on or before July 5, 2019. A $50 processing fee will be deducted from refund requests. NO REFUNDS WILL BE GIVEN AFTER July 5, 2019. Substitutions are allowed with advance notice. Refund and/or substitution requests must be received in writing by either email or fax. In the event of postponement or cancellation, a full registration refund will be given. The University of Florida is not responsible for travel arrangements, travel fees or any expense incurred by you as a result of such cancellation. If the University of Florida cancels this event, you will be contacted at the email address you provided when registering, so please be sure to provide a valid email address. Failure to appear at the event will result in forfeiture of the entire registration fee and credit.
Accommodations for Disabilities or Special Requests, Including Dietary
Please notify Dr. Bruce Goldberger a minimum of ten working days prior to the conference so that adequate consideration may be given to your request. Special dietary restrictions should also be submitted in advance.
Faculty Disclosure:
University of Florida College of Medicine adheres to the ACCME Standards regarding commercial support of continuing medical education. It is policy that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this education activity, that relevant conflicts of interest are resolved, and that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made in the course syllabus.
